2,3-diphosphoglycerate has been researched along with Inflammation in 2 studies
2,3-Diphosphoglycerate: A highly anionic organic phosphate which is present in human red blood cells at about the same molar ratio as hemoglobin. It binds to deoxyhemoglobin but not the oxygenated form, therefore diminishing the oxygen affinity of hemoglobin. This is essential in enabling hemoglobin to unload oxygen in tissue capillaries. It is also an intermediate in the conversion of 3-phosphoglycerate to 2-phosphoglycerate by phosphoglycerate mutase (EC 5.4.2.1). (From Stryer Biochemistry, 4th ed, p160; Enzyme Nomenclature, 1992, p508)
2,3-bisphosphoglyceric acid : A bisphosphoglyceric acid that is glyceric acid carrying two phospho substituents at positions 2 and 3.
Inflammation: A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sphingosine-1-phosphate (S1P) is emerging as a hypoxia responsive bio-lipid; systemically raised levels of S1P are proposed to have potential hypoxia pre-conditioning effects." | 7.96 | Preventive preclinical efficacy of intravenously administered sphingosine-1-phosphate (S1P) in strengthening hypoxia adaptive responses to acute and sub-chronic hypobaric hypoxia. ( Chawla, S; Rahar, B; Saxena, S; Tulswani, R, 2020) |
| "Sphingosine-1-phosphate (S1P) is emerging as a hypoxia responsive bio-lipid; systemically raised levels of S1P are proposed to have potential hypoxia pre-conditioning effects." | 3.96 | Preventive preclinical efficacy of intravenously administered sphingosine-1-phosphate (S1P) in strengthening hypoxia adaptive responses to acute and sub-chronic hypobaric hypoxia. ( Chawla, S; Rahar, B; Saxena, S; Tulswani, R, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chawla, S | 1 |
| Rahar, B | 1 |
| Tulswani, R | 1 |
| Saxena, S | 1 |
| Qiang, Q | 1 |
| Manalo, JM | 1 |
| Sun, H | 1 |
| Zhang, Y | 1 |
| Song, A | 1 |
| Wen, AQ | 1 |
| Wen, YE | 1 |
| Chen, C | 1 |
| Liu, H | 1 |
| Cui, Y | 1 |
| Nemkov, T | 1 |
| Reisz, JA | 1 |
| Edwards Iii, G | 1 |
| Perreira, FA | 1 |
| Kellems, RE | 1 |
| Soto, C | 1 |
| D'Alessandro, A | 1 |
| Xia, Y | 1 |
2 other studies available for 2,3-diphosphoglycerate and Inflammation
| Article | Year |
|---|---|
Preventive preclinical efficacy of intravenously administered sphingosine-1-phosphate (S1P) in strengthening hypoxia adaptive responses to acute and sub-chronic hypobaric hypoxia.
Topics: 2,3-Diphosphoglycerate; Administration, Intravenous; Animals; Biomarkers; Body Weight; Brain; Capill | 2020 |
Erythrocyte adenosine A2B receptor prevents cognitive and auditory dysfunction by promoting hypoxic and metabolic reprogramming.
Topics: 2,3-Diphosphoglycerate; Aging; Animals; Auditory Pathways; Bisphosphoglycerate Mutase; Brain; Cochle | 2021 |